Patient Planning Manager, Cell Therapy in Devens, MA at Bristol-Myers Squibb

Devens, Massachusetts, United States

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, Cell TherapyIndustries

Requirements

Advanced proficiency in Site Scheduling / planning / ERP systems and analytics tools (preferred)
Advanced knowledge of fundamental concepts of materials management, planning, and site production scheduling (preferred)
Certification in CPIM, CSCP, and/or CLTD (preferred but not required)
Ability to effectively communicate problem statements and viable solution options using pro vs. con and cost vs. benefit approaches
Ability to present data and analyses in an organized, clear, and concise manner
Advanced proficiency in MS Office applications
Excellent written and verbal communication skills
Ability to work (incomplete, but implied flexibility for shifts and up to 10% global travel)

Responsibilities

Act as the point of contact for Supply chain and the finite Scheduling team
Manage short term master production scheduling and manufacturing needs
Manage and communicate patient schedule changes and impact to approved production plan
Act as the point of contact for Cell Therapy Global Patient Scheduling (incoming & outgoing)
Manage the in-coming flow following patient apheresis material; partner with Cell Therapy Material Operations, Manufacturing, & Quality to ensure readiness for prompt receipt, inspection, and start of processing
Conduct investigation and root cause analyses on any supply disruptions or material quality issues and report on corrective actions
Manage secondary packaging of final drug product and return shipment to patients
Manage Site Supply Chain Standard Operating procedures
Own and manage deviations and corrective/preventive actions
Own and manage change controls
Foster a culture of compliance and strong environmental, health, and safety performance
Promote a mindset of continuous improvement and problem solving and prevention
Track and report metrics
Participate in and/or lead cross-functional teams to improve systems, processes, or internal/external performance

Skills

Supply Chain Planning

Logistics Planning

Product Scheduling

Patient Scheduling

Cold Chain Logistics

Shipping

Receiving

Stakeholder Coordination

Cell Therapy Manufacturing

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free